Ubiquitin-specific protease 20 regulates the reciprocal functions of β- Arrestin2 in toll-like receptor 4-promoted nuclear factor kB (NFkB) activation

Journal of Biological Chemistry

Volumn 291, Issue 14, 2016, Pages 7450-7464

  Jean Charles, Pierre Yves ^a   Zhang, Lisheng ^a   Wu, Jiao Hui ^a   Han, Sang Oh ^a   Brian, Leigh ^a   Freedman, Neil J ^a   Shenoy, Sudha K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSOCIATION REACTIONS; CELLS; CHEMICAL ACTIVATION; DISEASES; MUSCLE; PLANTS (BOTANY);

ANTI-INFLAMMATORY ACTIVITY; ANTI-INFLAMMATORY EFFECTS; DEUBIQUITINATING ENZYMES; INFLAMMATORY DISORDERS; INFLAMMATORY RESPONSE; MULTIFUNCTIONAL ADAPTOR PROTEINS; NEOINTIMAL HYPERPLASIA; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS;

PROTEINS;

BETA ARRESTIN 2; DEUBIQUITINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SIGNALOSOME; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN SPECIFIC PROTEASE 20; UNCLASSIFIED DRUG; BETA ARRESTIN; PROTEINASE; RETINA S ANTIGEN; TLR4 PROTEIN, MOUSE; USP20 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CAROTID ENDOTHELIAL DENUDATION; CATALYSIS; CONTROLLED STUDY; DEUBIQUITINATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; HUMAN CELL; HYPERPLASIA; IN VITRO STUDY; IN VIVO STUDY; MATRIX ATTACHMENT REGION; MOUSE; NEOINTIMAL HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA INTERFERENCE; SMOOTH MUSCLE CELL; TRANSGENIC MOUSE; UBIQUITINATION; ANIMAL; CELL LINE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ARRESTINS; BETA-ARRESTINS; CELL LINE; ENDOPEPTIDASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; UBIQUITINATION;

EID: 84965169006     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.687129     Document Type: Article

References (69)

1. DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) -Arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510.
2. Lefkowitz, R. J. (2013) Arrestins come of age: A personal historical perspective. Prog. Mol. Biol. Transl. Sci. 118, 3-18.
3. Lefkowitz, R. J., Rajagopal, K., and Whalen, E. J. (2006) New roles for - Arrestins in cell signaling: Not just for seven- Transmembrane receptors. Mol. Cell 24, 643-652.
4. Shenoy, S. K., and Lefkowitz, R. J. (2011) -Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci. 32, 521-533.
5. Kommaddi, R. P., and Shenoy, S. K. (2013) Arrestins and protein ubiquitination. Prog. Mol. Biol. Transl. Sci. 118, 175-204.
6. Wang, Y., Tang, Y., Teng, L., Wu, Y., Zhao, X., and Pei, G. (2006) Association of - Arrestin and TRAF6 negatively regulates Toll-like receptorinterleukin 1 receptor signaling. Nat. Immunol. 7, 139-147.
7. Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., and Pei, G. (2004) Identification of - Arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-B pathways. Mol. Cell 14, 303-317.
8. Witherow, D. S., Garrison, T. R., Miller, W. E., and Lefkowitz, R. J. (2004) -Arrestin inhibits NF-B activity by means of its interaction with the NF-B inhibitor I-B-. Proc. Natl. Acad. Sci. U.S.A. 101, 8603-8607.
9. Chen, Z. J. (2012) Ubiquitination in signaling to and activation of IKK. Immunol. Rev. 246, 95-106.
10. Skaug, B., Jiang, X., and Chen, Z. J. (2009) The role of ubiquitin in NF-B regulatory pathways. Annu. Rev. Biochem. 78, 769-796.
11. Fan, H., Bitto, A., Zingarelli, B., Luttrell, L. M., Borg, K., Halushka, P. V., and Cook, J. A. (2010) -Arrestin 2 negatively regulates sepsis-induced inflammation. Immunology 130, 344-351.
12. Fan, H., Luttrell, L. M., Tempel, G. E., Senn, J. J., Halushka, P. V., and Cook, J. A. (2007) -Arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol. Immunol. 44, 3092-3099.
13. Li, P., Cook, J. A., Gilkeson, G. S., Luttrell, L. M., Wang, L., Borg, K. T., Halushka, P. V., and Fan, H. (2011) Increased expression of - Arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol. Immunol. 49, 64-74.
14. Kim, J., Zhang, L., Peppel, K., Wu, J. H., Zidar, D. A., Brian, L., DeWire, S. M., Exum, S. T., Lefkowitz, R. J., and Freedman, N. J. (2008) -Arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ. Res. 103, 70-79.
15. Lovgren, A. K., Kovacs, J. J., Xie, T., Potts, E. N., Li, Y., Foster, W. M., Liang, J., Meltzer, E. B., Jiang, D., Lefkowitz, R. J., and Noble, P. W. (2011) -Arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci. Transl. Med. 3, 74ra23.
16. Walker, J. K., Fong, A. M., Lawson, B. L., Savov, J. D., Patel, D. D., Schwartz, D. A., and Lefkowitz, R. J. (2003) -Arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112, 566-574.
17. Zernecke, A., and Weber, C. (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res. Cardiol. 100, 93-101.
18. Zhang L, Peppel, K., Sivashanmugam P, Orman ES, Brian L, Exum ST, Freedman NJ. (2007) Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 1087-1094.
19. Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., RaJavashisth, T. B., and Arditi, M. (2004) Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 101, 10679-10684.
20. Libby, P. (2012) Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 2045-2051.
21. Sun, J., and Lin, X. (2008) -Arrestin 2 is required for lysophosphatidic acid-induced NF-B activation. Proc. Natl. Acad. Sci. U.S.A. 105, 17085-17090.
22. Shenoy, S. K., Barak, L. S., Xiao, K., Ahn, S., Berthouze, M., Shukla, A. K., Luttrell, L. M., and Lefkowitz, R. J. (2007) Ubiquitination of - Arrestin links seven- Transmembrane receptor endocytosis and ERK activation. J. Biol. Chem. 282, 29549-29562.
23. Shenoy, S. K., Modi, A. S., Shukla, A. K., Xiao, K., Berthouze, M., Ahn, S., Wilkinson, K. D., Miller, W. E., and Lefkowitz, R. J. (2009) -Arrestin-dependent signaling and trafficking of 7- Transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc. Natl. Acad. Sci. U.S.A. 106, 6650-6655.
24. Yasunaga, J., Lin, F. C., Lu, X., and Jeang, K. T. (2011) Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-B signaling. J. Virol. 85, 6212-6219.
25. Berthouze, M., Venkataramanan, V., Li, Y., and Shenoy, S. K. (2009) The deubiquitinases USP33 and USP20 coordinate -2 adrenergic receptor recycling and resensitization. EMBO J. 28, 1684-1696.
26. Kemp, P. R., Osbourn, J. K., Grainger, D. J., and Metcalfe, J. C. (1995) Cloning and analysis of the promoter region of the rat SM22 - gene. Biochem. J. 310, 1037-1043.
27. Osbourn, J. K., Weissberg, P. L., and Shanahan, C. M. (1995) A regulatory element downstream of the rat SM22 - gene transcription start point enhances reporter gene expression in vascular smooth muscle cells. Gene 154, 249-253.
28. Keys, J. R., Zhou, R. H., Harris, D. M., Druckman, C. A., and Eckhart, A. D. (2005) Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling. Circulation 112, 1145-1153.
29. Kohout, T. A., Lin, F. S., Perry, S. J., Conner, D. A., and Lefkowitz, R. J. (2001) -Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. U.S.A. 98, 1601-1606.
30. Xiao, K., Shenoy, S. K., Nobles, K., and Lefkowitz, R. J. (2004) Activationdependent conformational changes in - Arrestin 2. J. Biol. Chem. 279, 55744-55753.
31. Wu, J. H., Zhang, L., Fanaroff, A. C., Cai, X., Sharma, K. C., Brian, L., Exum, S. T., Shenoy, S. K., Peppel, K., and Freedman, N. J. (2012) G proteincoupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7- Transmembrane receptors. Arterioscler. Thromb. Vasc. Biol. 32, 308-316.
32. Cai, X., Wu, J. H., Exum, S. T., Oppermann, M., Premont, R. T., Shenoy, S. K., and Freedman, N. J. (2009) Reciprocal regulation of the plateletderived growth factor receptor- AndGprotein-coupled receptor kinase 5 by cross-phosphorylation: Effects on catalysis. Mol. Pharmacol. 75, 626-636.
33. Shenoy, S. K., McDonald, P. H., Kohout, T. A., and Lefkowitz, R. J. (2001) Regulation of receptor fate by ubiquitination of activated - 2- Adrenergic receptor and - Arrestin. Science 294, 1307-1313.
34. Wu, J. H., Peppel, K., Nelson, C. D., Lin, F. T., Kohout, T. A., Miller, W. E., Exum, S. T., and Freedman, N. J. (2003) The adaptor protein - Arrestin2 enhances endocytosis of the low density lipoprotein receptor. J. Biol. Chem. 278, 44238-44245.
35. Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., and Lefkowitz, R. J. (2006) -Arrestin-dependent, G protein-independent ERK1/2 activation by the -2 adrenergic receptor. J. Biol. Chem. 281, 1261-1273.
36. Han, S. O., Xiao, K., Kim, J., Wu, J. H., Wisler, J. W., Nakamura, N., Freedman, N. J., and Shenoy, S. K. (2012) MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound -(2)- Adrenergic receptors. J. Cell Biol. 199, 817-830.
37. Han, S. O., Kommaddi, R. P., and Shenoy, S. K. (2013) Distinct roles for - Arrestin2 and arrestin-domain-containing proteins in -2 adrenergic re-ceptor trafficking. EMBO Rep. 14, 164-171.
38. Luttrell, L. M., and Miller, W. E. (2013) Arrestins as regulators of kinases and phosphatases. Prog. Mol. Biol. Transl. Sci. 118, 115-147.
39. Kang, D. S., Tian, X., and Benovic, J. L. (2014) Role of - Arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr. Opin. Cell Biol. 27, 63-71.
40. Li, L., Miano, J. M., Mercer, B., and Olson, E. N. (1996) Expression of the SM22- promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J. Cell Biol. 132, 849-859.
41. Solway, J., Seltzer, J., Samaha, F. F., Kim, S., Alger, L. E., Niu, Q., Morrisey, E. E., Ip, H. S., and Parmacek, M. S. (1995) Structure and expression of a smooth muscle cell-specific gene, SM22 -. J. Biol. Chem. 270, 13460-13469.
42. Squadrito, F., Deodato, B., Bova, A., Marini, H., Saporito, F., Calò, M., Giacca, M., Minutoli, L., Venuti, F. S., Caputi, A. P., and Altavilla, D. (2003) Crucial role of nuclear factor-B in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow. Atherosclerosis 166, 233-242.
43. Wang, X., Chai, H., Lin, P. H., Lumsden, A. B., Yao, Q., and Chen, C. (2006) Mouse models of neointimal hyperplasia: Techniques and applications. Med. Sci. Monit. 12, RA177- RA185.
44. Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., and Saiki, I. (2003) Tumor necrosis factor-induced IKK phosphorylation of NF-B p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278, 36916-36923.
45. Yang, F., Tang, E., Guan, K., and Wang, C. Y. (2003) IKK - plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J. Immunol. 170, 5630-5635.
46. Li, Q., and Verma, I. M. (2002) NF-B regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
47. Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z., and Collins, T. (1992) Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med. 176, 1583-1593.
48. Zhang, L. L., Gao, C. Y., Fang, C. Q., Wang, Y. J., Gao, D., Yao, G. E., Xiang, J., Wang, J. Z., and Li, J. C. (2011) PPAR- Attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Cardiovasc. Res. 92, 484-493.
49. Stoll, L. L., Denning, G. M., and Weintraub, N. L. (2006) Endotoxin, TLR4 signaling and vascular inflammation: Potential therapeutic targets in cardiovascular disease. Curr. Pharm. Des. 12, 4229-4245.
50. Shenoy, S. K., and Lefkowitz, R. J. (2003) Trafficking patterns of- Arrestin and G protein-coupled receptors determined by the kinetics of - Arrestin deubiquitination. J. Biol. Chem. 278, 14498-14506.
51. Ventii, K. H., and Wilkinson, K. D. (2008) Protein partners of deubiquitinating enzymes. Biochem. J. 414, 161-175.
52. Hou, B., Eren, M., Painter, C. A., Covington, J. W., Dixon, J. D., Schoenhard, J. A., and Vaughan, D. E. (2004) Tumor necrosis factor - Activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor -B site. J. Biol. Chem. 279, 18127-18136.
53. Lokeshwar, V. B., Gomez, P., Kramer, M., Knapp, J., McCornack, M. A., Lopez, L. E., Fregien, N., Dhir, N., Scherer, S., Klumpp, D. J., Manoharan, M., Soloway, M. S., and Lokeshwar, B. L. (2008) Epigenetic regulation of HYAL-1 hyaluronidase expression: identification of HYAL-1 promoter. J. Biol. Chem. 283, 29215-29227.
54. Massagué, J. (2012) TGF- signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630.
55. Chen, Z. J. (2005) Ubiquitin signalling in the NF-B pathway. Nat. Cell Biol. 7, 758-765.
56. Poole, E., King, C. A., Sinclair, J. H., and Alcami, A. (2006) The UL144 gene product of human cytomegalovirus activates NF-B via a TRAF6-dependent mechanism. EMBO J. 25, 4390-4399.
57. Nijman, S. M., Luna-Vargas, M.P., Velds, A., Brummelkamp, T.R., Dirac, A.M., Sixma, T.K., and Bernards. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786.
58. Clague, M. J., Coulson, J. M., and Urbé, S. (2012) Cellular functions of the DUBs. J. Cell Sci. 125, 277-286.
59. Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., and Sun, S. C. (2008) Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J. Clin. Invest. 118, 1858-1866.
60. Harhaj, E. W., and Dixit, V. M. (2011) Deubiquitinases in the regulation of NF-B signaling. Cell Res 21, 22-39.
61. Zhang, J., Stirling, B., Temmerman, S. T., Ma, C. A., Fuss, I. J., Derry, J. M., and Jain, A. (2006) Impaired regulation of NF-B and increased susceptibility to colitis- Associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116, 3042-3049.
62. Beyaert, R., Heyninck, K., and Van Huffel, S. (2000) A20 and A20-binding proteins as cellular inhibitors of nuclear factor- B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143-1151.
63. Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R. C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., McNally, E., Pickart, C., and Ma, A. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060.
64. Shembade, N., and Harhaj, E. W. (2012) Regulation of NF-B signaling by the A20 deubiquitinase. Cell. Mol. Immunol. 9, 123-130.
65. Wolfrum, S., Teupser, D., Tan, M., Chen, K. Y., and Breslow, J. L. (2007) The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-B target genes. Proc. Natl. Acad. Sci. U.S.A. 104, 18601-18606.
66. De, A., Dainichi, T., Rathinam, C. V., and Ghosh, S. (2014) The deubiquitinase activity of A20 is dispensable for NF-B signaling. EMBO Rep. 15, 775-783.
67. Kommaddi, R. P., Jean-Charles, P. Y., and Shenoy, S. K. (2015) Phosphorylation of the deubiquitinase USP20 by protein kinase A regulates postendocytic trafficking of -2 adrenergic receptors to autophagosomes during physiological stress. J. Biol. Chem. 290, 8888-8903.
68. Janssens, S., and Beyaert, R. (2003) Functional diversity and regulation of different interleukin-1 receptor- Associated kinase (IRAK) family members. Mol. Cell 11, 293-302.
69. McDonald, P. H., Chow, C. W., Miller, W. E., Laporte, S. A., Field, M. E., Lin, F. T., Davis, R. J., and Lefkowitz, R. J. (2000) -Arrestin 2: A receptorregulated MAPK scaffold for the activation of JNK3. Science 290, 1574-1577.